ArticleTranslational vision science & technology2025
An Intelligent Grading Model for Myopic Maculopathy Based on Long-Tailed Learning.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence for pathologic myopia classification based on the META-PM system: a systematic review and meta-analysis.Frontiers in physiology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To develop an intelligent grading model for myopic maculopathy based on a long-tail learning framework, using the improved loss function LTBSoftmax. The model addresses the long-tail distribution problem in myopic maculopathy data to provide preliminary grading, aiming to improve grading capability and efficiency. Methods: This study includes a data set of 7529 color fundus photographs. Experienced ophthalmologists meticulously annotated the ground truth. A new intelligent grading model for myopic maculopathy was constructed using the improved loss function LTBSoftmax, which predicts lesions by locally enhancing feature extraction with ND Block. Standard grading metrics were selected to evaluate the LTBSoftmax model. Results: The improved model demonstrated excellent performance in diagnosing four types of myopic maculopathy, achieving a κ coefficient of 88.89%. Furthermore, the model's size is 18.7 MB, which is relatively smaller compared to traditional models, indicating that the model not only achieves a high level of agreement with expert diagnoses but is also more efficient in terms of both storage and computational resources. These metrics further validate the model's well-conceived design and superiority in practical applications. Conclusions: The intelligent grading system, using long-tailed learning strategies, effectively improves the classification of myopic maculopathy, offering a practical grading tool for clinicians, particularly in areas with limited resources. Translational Relevance: This model translates long-tail learning research into a practical grading tool for myopic maculopathy. It addresses data imbalance with the improved LTBSoftmax loss function, achieving high accuracy and efficiency. By enhancing feature extraction with ND Block, it provides reliable grading support for clinicians, especially in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.